HCSG Quote, Financials, Valuation and Earnings

Encompass Health has a net margin of 3.85% compared to Healthcare Services Group's net margin of 10.41%. Healthcare Services Group's return on equity of 8.45% beat Encompass Health's return on equity of 18.4%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 3.88%. On the other hand Encompass Health has an analysts' consensus of $131.58 which suggests that it could grow by 8.26%. Given that Encompass Health has higher upside potential than Healthcare Services Group, analysts believe Encompass Health is more attractive than Healthcare Services Group.

Healthcare Services Group has a beta of 0.554, which suggesting that the stock is 44.573% less volatile than S&P 500. In comparison Encompass Health has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.671%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.54% to investors and pays a quarterly dividend of $0.17 per share. Healthcare Services Group pays -- of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Healthcare Services Group quarterly revenues are $447.7M, which are smaller than Encompass Health quarterly revenues of $1.5B. Healthcare Services Group's net income of $17.2M is lower than Encompass Health's net income of $151.5M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.79x while Encompass Health's PE ratio is 25.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.61x versus 2.25x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

Surgery Partners has a net margin of 3.85% compared to Healthcare Services Group's net margin of -4.86%. Healthcare Services Group's return on equity of 8.45% beat Surgery Partners's return on equity of -5.45%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 3.88%. On the other hand Surgery Partners has an analysts' consensus of $31.36 which suggests that it could grow by 35.25%. Given that Surgery Partners has higher upside potential than Healthcare Services Group, analysts believe Surgery Partners is more attractive than Healthcare Services Group.

Healthcare Services Group has a beta of 0.554, which suggesting that the stock is 44.573% less volatile than S&P 500. In comparison Surgery Partners has a beta of 1.931, suggesting its more volatile than the S&P 500 by 93.143%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. Surgery Partners pays out -- of its earnings as a dividend.

Healthcare Services Group quarterly revenues are $447.7M, which are smaller than Surgery Partners quarterly revenues of $776M. Healthcare Services Group's net income of $17.2M is higher than Surgery Partners's net income of -$37.7M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.79x while Surgery Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.61x versus 0.92x for Surgery Partners. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute has a net margin of 3.85% compared to Healthcare Services Group's net margin of -18.76%. Healthcare Services Group's return on equity of 8.45% beat The Oncology Institute's return on equity of -340.01%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 3.88%. On the other hand The Oncology Institute has an analysts' consensus of $7.00 which suggests that it could grow by 152.25%. Given that The Oncology Institute has higher upside potential than Healthcare Services Group, analysts believe The Oncology Institute is more attractive than Healthcare Services Group.

Healthcare Services Group has a beta of 0.554, which suggesting that the stock is 44.573% less volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

Healthcare Services Group quarterly revenues are $447.7M, which are larger than The Oncology Institute quarterly revenues of $104.4M. Healthcare Services Group's net income of $17.2M is higher than The Oncology Institute's net income of -$19.6M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.79x while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.61x versus 0.52x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.